Literature DB >> 33572400

The Evolving Landscape of Fungal Diagnostics, Current and Emerging Microbiological Approaches.

Zoe Freeman Weiss1,2, Armando Leon1, Sophia Koo1.   

Abstract

Invasive fungal infections are increasingly recognized in immunocompromised hosts. Current diagnostic techniques are limited by low sensitivity and prolonged turnaround times. We review emerging diagnostic technologies and platforms for diagnosing the clinically invasive disease caused by Candida, Aspergillus, and Mucorales.

Entities:  

Keywords:  culture independent; fungal diagnostics; immunocompromised host; invasive aspergillosis; invasive candidiasis; invasive mold infections; mucormycosis; mycoses; non-culture diagnostics; transplant

Year:  2021        PMID： 33572400      PMCID： PMC7916227          DOI： 10.3390/jof7020127

Source DB:  PubMed          Journal:  J Fungi (Basel)        ISSN： 2309-608X


  146 in total

1.  Molecular identification of Mucorales in human tissues: contribution of PCR electrospray-ionization mass spectrometry.

Authors:  A Alanio; D Garcia-Hermoso; S Mercier-Delarue; F Lanternier; M Gits-Muselli; J Menotti; B Denis; A Bergeron; M Legrand; O Lortholary; S Bretagne
Journal:  Clin Microbiol Infect       Date:  2015-01-28       Impact factor: 8.067

Review 2.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.

Authors:  Eleftherios Mylonakis; Cornelius J Clancy; Luis Ostrosky-Zeichner; Kevin W Garey; George J Alangaden; Jose A Vazquez; Jeffrey S Groeger; Marc A Judson; Yuka-Marie Vinagre; Stephen O Heard; Fainareti N Zervou; Ioannis M Zacharioudakis; Dimitrios P Kontoyiannis; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2015-01-12       Impact factor: 9.079

4.  Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification.

Authors:  David S Perlin; Nathan P Wiederhold
Journal:  J Infect Dis       Date:  2017-08-15       Impact factor: 5.226

Review 5.  PCR diagnosis of invasive candidiasis: systematic review and meta-analysis.

Authors:  Tomer Avni; Leonard Leibovici; Mical Paul
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

6.  Development of a Dual Path Platform (DPP®) immunoassay for rapid detection of Candida albicans in human whole blood and serum.

Authors:  Milan Gunasekera; Mohanlall Narine; Matthew Ashton; Javan Esfandiari
Journal:  J Immunol Methods       Date:  2015-05-15       Impact factor: 2.303

7.  Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients.

Authors:  R Zaragoza; J Pemán; G Quindós; J R Iruretagoyena; M S Cuétara; P Ramírez; M D Gómez; J J Camarena; A Viudes; J Pontón
Journal:  Clin Microbiol Infect       Date:  2009-05-11       Impact factor: 8.067

Review 8.  Galactomannan detection for invasive aspergillosis in immunocompromised patients.

Authors:  Mariska M G Leeflang; Yvette J Debets-Ossenkopp; Junfeng Wang; Caroline E Visser; Rob J P M Scholten; Lotty Hooft; Henk A Bijlmer; Johannes B Reitsma; Mingming Zhang; Patrick M M Bossuyt; Christina M Vandenbroucke-Grauls
Journal:  Cochrane Database Syst Rev       Date:  2015-12-30

9.  Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.

Authors:  Preeti Pancholi; Karen C Carroll; Donna M Wolk; Blake W Buchan; Raymond C Chan; Neelam Dhiman; Bradley Ford; Paul A Granato; Amanda T Harrington; Diana R Hernandez; Romney M Humphries; Matthew R Jindra; Nathan A Ledeboer; Shelley A Miller; A Brian Mochon; Margie A Morgan; Robin Patel; Paul C Schreckenberger; Paul D Stamper; Patricia J Simner; Nancy E Tucci; Cynthia Zimmerman
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

10.  Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial.

Authors:  Hossein Salimnia; Marilynn R Fairfax; Paul R Lephart; Paul Schreckenberger; Sharon M DesJarlais; J Kristie Johnson; Gwen Robinson; Karen C Carroll; Amy Greer; Margie Morgan; Raymond Chan; Michael Loeffelholz; Frances Valencia-Shelton; Stephen Jenkins; Audrey N Schuetz; Judy A Daly; Trenda Barney; Andrew Hemmert; Kristen J Kanack
Journal:  J Clin Microbiol       Date:  2016-01-06       Impact factor: 5.948
View more
  3 in total

1.  A multisite evaluation of antifungal use in critical care: implications for antifungal stewardship.

Authors:  C Logan; C Hemsley; A Fife; J Edgeworth; A Mazzella; P Wade; A Goodman; P Hopkins; D Wyncoll; J Ball; T Planche; S Schelenz; T Bicanic
Journal:  JAC Antimicrob Resist       Date:  2022-06-23

2.  Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study.

Authors:  Gowri Satyanarayana; Kyle T Enriquez; Tianyi Sun; Elizabeth J Klein; Maheen Abidi; Shailesh M Advani; Joy Awosika; Ziad Bakouny; Babar Bashir; Stephanie Berg; Marilia Bernardes; Pamela C Egan; Arielle Elkrief; Lawrence E Feldman; Christopher R Friese; Shipra Goel; Cyndi Gonzalez Gomez; Keith L Grant; Elizabeth A Griffiths; Shuchi Gulati; Shilpa Gupta; Clara Hwang; Jayanshu Jain; Chinmay Jani; Anna Kaltsas; Anup Kasi; Hina Khan; Natalie Knox; Vadim S Koshkin; Daniel H Kwon; Chris Labaki; Gary H Lyman; Rana R McKay; Christopher McNair; Gayathri Nagaraj; Elizabeth S Nakasone; Ryan Nguyen; Taylor K Nonato; Adam J Olszewski; Orestis A Panagiotou; Matthew Puc; Pedram Razavi; Elizabeth V Robilotti; Miriam Santos-Dutra; Andrew L Schmidt; Dimpy P Shah; Sumit A Shah; Kendra Vieira; Lisa B Weissmann; Trisha M Wise-Draper; Ulysses Wu; Julie Tsu-Yu Wu; Toni K Choueiri; Sanjay Mishra; Jeremy L Warner; Benjamin French; Dimitrios Farmakiotis
Journal:  Open Forum Infect Dis       Date:  2022-02-14       Impact factor: 4.423

3.  Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans.

Authors:  Genna E Davies; Christopher R Thornton
Journal:  J Fungi (Basel)       Date:  2022-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.